Wound Debridement Market Analysis | 2022-2028

Market Insights

The Wound Debridement Market was estimated at US$ 4.29 billion in 2021 and is expected to grow at a CAGR of 6.29% during 2022-2028 to reach US$ 6.6 billion in 2028.

Wish to get a free sample? Register Here

What is wound debridement?

Wound debridement is a medical procedure involving the removal of non-viable, infected, or damaged tissue from a wound to promote healing. This process aims to create a clean and healthy environment for the remaining tissue to regenerate. Debridement can be achieved through various methods, including surgical excision, enzymatic agents, mechanical irrigation, or autolytic dressings. By eliminating dead or contaminated tissue, debridement facilitates better oxygenation, reduces the risk of infection, and enhances the body's natural ability to repair itself. This critical step is commonly employed in the treatment of chronic wounds, burns, and other injuries to optimize the overall healing process.

Market Dynamics

The market is expected to be driven by the growing prevalence of chronic illnesses such as pressure ulcers, and diabetic foot ulcers, as well as other target wounds, the accessibility of reimbursement in advanced economies, and changing lifestyles. Furthermore, the growing occurrence of accidents such as car accidents, burns, and trauma events around the world is expected to drive the market. Furthermore, the growing senior population and increased attempts by governments and private groups to improve awareness about wound care therapy are expected to benefit the market.

Furthermore, the growing use of debridement products and techniques to speed up wound healing is fueling market expansion. The presence of microorganisms and toxins in the wound inhibits healing and may cause infections. Debridement is the removal of dead or contaminated tissues from a wound to promote healing. The increased incidence of ulcers is expected to drive market expansion even more. Awareness campaigns for wound care are required. Furthermore, the availability of improved healthcare facilities, the acceptance of innovative wound care products, the development of healthcare infrastructure, as well as reimbursement policies are propelling the market.

Several investments/guidelines in the market have been directed in recent years, which would boost the overall market. Some of them are:

• The APAC market is predicted to increase due to a progressive economy, infrastructure changes, a huge population with unmet requirements, and the availability of a trained workforce. For example, the implementation of the Goods and Services Tax (GST) in India is expected to lessen the tax burden and its impact.

Segments Analysis

By Wound Type

The market is further segmented into pressure ulcers, diabetic foot ulcers, venous leg ulcers, burn wound, and others. Because of the growing number of diabetic foot ulcer patients, the diabetic foot ulcers segment dominated the market in 2021. Due to an increase in the prevalence of various disorders that necessitate a prolonged hospital stay, the pressure ulcers category is predicted to expand at the fastest CAGR over the forecast period.

Diabetic foot ulcers are among the most prevalent types of chronic sores and are primarily caused by uncontrolled diabetes mellitus. Diabetes ulcers are often painless and necessitate a lengthy hospital stay. The rising global incidence of diabetic foot ulcers is a primary element driving category expansion.

By Product Type

The wound debridement market has been divided into gels, ointment & creams, surgical devices, medical gauzes, ultrasonic devices, and others. In 2021, medical gauze and pads experienced their greatest market share. Medical gauzes aid in keeping the wound wet, allowing for faster healing. Wound dressings are highly recommended for chronic wounds such as diabetic ulcers, burn injuries, pressure ulcers, and other slow-healing wounds because they promote speedier healing. Gauzes are mostly made up of collagen, hydrocolloids, hydrogels, foams, and alginates.

Due to their increasing demand and extensive range of uses in the treatment of various wounds, gels held the second-largest share in 2021. During the projected period, the ultrasonic devices sector is expected to grow at the fastest CAGR. This is owing to benefits such as the capacity to eliminate bacteria at the wound site without causing damage to the blood vessels. Gels maintain a moist wound environment and have advantages over other products.

Gels are amorphous and clear hydrogels that are mostly utilized to heal sloughy and necrotic tissue in chronic wounds. Increasing incidences of surgical wounds or Surgical Site Infection (SSI) among patients, as well as an increase in chronic wounds, particularly diabetic foot ulcers, are among the primary drivers driving category expansion.

By Method Type

The market is segmented into autolytic, enzymatic, surgical, mechanical, and others. In 2021, the surgical wound debridement segment dominated the market. It is the quickest wound debridement treatment for achieving a clean wound bed, aiding segment growth. During the projection period, the autolytic wound debridement segment is predicted to grow at the fastest CAGR. The market is divided into autolytic, enzymatic, surgical, mechanical, and others based on method/procedure.

The elimination of necrotic debris and damaged tissues from a wound site by the body's endogenous enzymes that engulf particular components of body tissues/cells is known as autolytic debridement. This approach is usually comfortable and successful, but it takes longer than other debridement treatments. If sufficient autolysis is not noticed within 1-2 weeks, another type of debridement should be used.

By End-User Type 

The hospitals segment dominated the market. During the projection period, the homecare category is expected to grow at the fastest CAGR.  The market is divided into hospitals, homecare, and others based on end-use. A crucial element driving the hospitals segment is the rising prevalence of chronic wounds such as diabetic foot ulcers and venous leg ulcers.

Furthermore, the prevalence of chronic wounds is predicted to rise with age, posing a considerable financial burden on society. Every year, the healthcare system in the United States spends more than USD 25 billion on treating wound-related problems. Furthermore, the American Diabetes Association (ADA) estimates that 9-12 million individuals in the United States have chronic ulcers.

Regional Analysis

The wound debridement market is broken down geographically into geographies: North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2020, North America held a >30% share of the market. This can be linked to an increase in the number of operations, an increase in diabetes cases, and the presence of important market participants. Asia Pacific is predicted to develop at the quickest rate from 2021 to 2028, owing to reasons such as an aging population, improved healthcare infrastructure, and the presence of a huge patient base.

Key Players

The following are the key players in the wound debridement market:

• Abbott Medical Optics, Inc.
• Alcon Inc. (Novartis AG)
• Bausch & Lomb Incorporated
• Carl Zeiss
• IRIDEX Corporation
• IVIS Technologies
• LENSAR, LLC
• Lumenis
• NIDEK CO., LTD
• SCHWIND eye-tech-solutions GmbH & Co. KG.
• Topcon Corporation
• Ziemer Ophthalmic Systems AG

To achieve a larger market share, key market players are engaging in various strategic initiatives such as collaborations, regional growth, service portfolio expansion, mergers, and acquisitions. To ensure a smooth operation, several hospitals outsource their wound care directly to market participants.

For example,

• Healogics provides hospitals with an outpatient wound care clinic designed to cure difficult wounds. It contributes to cost savings and increases income creation. It also offers inpatient consultations at over 60 partner hospitals. The company introduced Healogics 2021 in January 2021. This Healing initiative provides information to patients and healthcare providers to help them improve their health, heal wounds, and avoid unnecessary amputations. Such improvements are having a favorable impact on market growth.

Research Methodology

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.  More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data.  We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

Report Features

This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

What Deliverables Will You Get in this Report?

Customization Options

With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

• Detailed profiling of additional market players (up to three players)
• SWOT analysis of key players (up to three players)

Competitive Benchmarking

• Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

Custom Research: Stratview Research offers custom research services across the sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com